These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2739862)

  • 21. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Food Sci; 2011 Sep; 76(7):H165-74. PubMed ID: 22417553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deposition of basement membrane in vitro by normal and diabetic rat renal glomeruli.
    Cohen MP; Dasmahapatra A; Wu VY
    Nephron; 1981; 27(3):146-51. PubMed ID: 7219644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies of collagen metabolism in glomerular basement membrane in the pathogenesis of diabetic nephropathy].
    Satoh M
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):913-26. PubMed ID: 3244190
    [No Abstract]   [Full Text] [Related]  

  • 25. Structural and functional changes in diabetic glomerulopathy.
    Schleicher E; Kolm V; Ceol M; Nerlich A
    Kidney Blood Press Res; 1996; 19(5):305-15. PubMed ID: 8956243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry of the basement membrane in diabetes mellitus.
    Brownlee M; Spiro RG
    Adv Exp Med Biol; 1979; 124():141-56. PubMed ID: 388998
    [No Abstract]   [Full Text] [Related]  

  • 27. Microvascular basement membranes in diabetes mellitus.
    Tsilibary EC
    J Pathol; 2003 Jul; 200(4):537-46. PubMed ID: 12845621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic glomerulosclerosis: current status.
    Kalant N
    Can Med Assoc J; 1978 Jul; 119(2):146-53. PubMed ID: 354765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of diabetic nephropathy. Insights from cell culture studies and animal models.
    Phillips A; Janssen U; Floege J
    Kidney Blood Press Res; 1999; 22(1-2):81-97. PubMed ID: 10352411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications.
    Li Y; Zhao M; He D; Zhao X; Zhang W; Wei L; Huang E; Ji L; Zhang M; Willard B; Fu Z; Wang L; Pan B; Zheng L; Ji L
    Lipids Health Dis; 2016 Apr; 15():76. PubMed ID: 27074994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?
    Kanková K
    Proc Nutr Soc; 2008 Feb; 67(1):60-74. PubMed ID: 18234133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary excretion of glycated albumin in insulin-dependent diabetic patients with micro- and macroalbuminuria.
    Cavallo-Perin P; Chiambretti A; Calefato V; Tomalino M; Cecchini G; Gruden G; Pagano G
    Clin Nephrol; 1992 Jul; 38(1):9-13. PubMed ID: 1499172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation into the biochemical basis of diabetic basement-membrane alterations.
    Sprio RG
    Diabetes; 1976; 25(2 SUPPL):909-13. PubMed ID: 786762
    [No Abstract]   [Full Text] [Related]  

  • 36. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunohistochemical localization of various components of the basal membrane and interstitial collagen in diabetic nephropathy].
    Nerlich A; Schleicher E
    Verh Dtsch Ges Pathol; 1989; 73():133-8. PubMed ID: 2482599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy.
    Kumar Pasupulati A; Chitra PS; Reddy GB
    Biomol Concepts; 2016 Dec; 7(5-6):293-309. PubMed ID: 27816946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical and morphological changes in the glomerulus in diabetes mellitus].
    Westberg NG
    Lakartidningen; 1979 Aug; 76(35):2878-81. PubMed ID: 502651
    [No Abstract]   [Full Text] [Related]  

  • 40. Search for a biochemical basis of diabetic microangiopathy.
    Spiro RG
    Diabetologia; 1976 Mar; 12(1):1-14. PubMed ID: 767187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.